JUN 9, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Azacitidine (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval for labeling changes to azacitidine generic product; does not report clinical efficacy or safety data.
Reported
Approval date2026-06-09
Strength100MG/VIAL